Literature DB >> 6228501

Combinations of increased thrombin, plasmin and non-specific protease activity in patients with acute leukaemia.

M J Galloway, M J Mackie, B A McVerry.   

Abstract

Thrombin generation, plasmin formation and non-specific protease activity, were assessed in a cohort group of 30 patients presenting with acute leukaemia. Abnormalities detected by specific tests of one or more of these three systems were found in 27 (90%) of patients while abnormalities in 'routine' laboratory coagulation tests were seen in only 17 (56%). All patients at presentation had a bleeding tendency which was defined as minor (skin purpura) or major (other bleeding sites). Patients presenting with minor (n = 19) or major haemorrhage (n = 11) could not be differentiated by the degree of thrombocytopenia. Similarly, increased generation of either thrombin or plasmin activity alone was non-discriminatory. However, more complex alterations of haemostasis involving increased activity of more than one of these three systems were seen only in those patients who had major haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6228501     DOI: 10.1159/000214771

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  3 in total

1.  Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia.

Authors:  I Pabinger; P Bettelheim; R Dudczak; W Hinterberger; P A Kyrle; H Niessner; I Schwarzinger; W Speiser; K Lechner
Journal:  Ann Hematol       Date:  1991-05       Impact factor: 3.673

2.  Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: activation of blood coagulation, fibrinolysis and unspecific proteolysis.

Authors:  W Speiser; I Pabinger-Fasching; P A Kyrle; S Kapiotis; A Kottas-Heldenberg; P Bettelheim; K Lechner
Journal:  Blut       Date:  1990-11

Review 3.  Haemostasis in malignant disease.

Authors:  M J Auger; M J Mackie
Journal:  J R Coll Physicians Lond       Date:  1988-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.